Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin for Adipose Tissue Repair in HFrEF and T2DM
NCT06240403Phase 2Not yet recruiting
- Sponsor
- University of Leeds
- Start
- Sep 2025
- Primary completion
- Aug 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin in heart failure with reduced ejection fraction (HFrEF), type 2 diabetes mellitus (T2DM), sponsored by University of Leeds. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
digoxin
03
Conditions
heart failure with reduced ejection fraction (HFrEF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06240403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06240403.